@nejm.org Evidence will publish a section in association with @cidrap.bsky.social on public health and vaccine issues usually covered by the now-dead MMWR
www.statnews.com/2025/10/21/c...
#publicHealth #MedSky
@nejm.org Evidence will publish a section in association with @cidrap.bsky.social on public health and vaccine issues usually covered by the now-dead MMWR
www.statnews.com/2025/10/21/c...
#publicHealth #MedSky
retractionwatch.com/2025/10/24/d...
#TransplantEthics
retractionwatch.com/2025/10/24/d...
#TransplantEthics
Iptacopan in C3GN makes it to @thelancet.com
www.thelancet.com/journals/lan...
#NephSky
Iptacopan in C3GN makes it to @thelancet.com
www.thelancet.com/journals/lan...
#NephSky
www.nejm.org/doi/full/10....
Aldosterone synthase inhibitors - first one to finish the phase 3 line
#Lorundrostat #Hypertension
www.nejm.org/doi/full/10....
Aldosterone synthase inhibitors - first one to finish the phase 3 line
#Lorundrostat #Hypertension
Subheader: Like metformin in Stage 4 CKD, this won’t clear quickly...but we added jokes!
Subheader: Like metformin in Stage 4 CKD, this won’t clear quickly...but we added jokes!
CKD-EPI, MDRD etc give us GFR corrected for body surface area (ml/min/1.73m2)
BUT we're supposed to use the *absolute* GFR (ml/min) for drug dosing (eg KDIGO 2024 guidelines below; FDA agrees)
in obesity, the computer's ml/min/1.73m2 can be way too low #EMIMCC
CKD-EPI, MDRD etc give us GFR corrected for body surface area (ml/min/1.73m2)
BUT we're supposed to use the *absolute* GFR (ml/min) for drug dosing (eg KDIGO 2024 guidelines below; FDA agrees)
in obesity, the computer's ml/min/1.73m2 can be way too low #EMIMCC
Correlates of Nocturnal Hypertension
academic.oup.com/ajh/article/...
#OpenAccess and #Free
Correlates of Nocturnal Hypertension
academic.oup.com/ajh/article/...
#OpenAccess and #Free
Spoiler: 🤝 😎 #NephroContinue
🔗 Yes: academic.oup.com/ndt/article/...
🔗 No: academic.oup.com/ndt/article/...
Spoiler: 🤝 😎 #NephroContinue
🔗 Yes: academic.oup.com/ndt/article/...
🔗 No: academic.oup.com/ndt/article/...
The 2025 Paul Farmer Lectureship and Award for Global Health Equity
www.mcgill.ca/spgh/about-u...
When I see fires, floods & hurricanes I immediately think “what about the dialysis patients?” #NephMadness
When I see fires, floods & hurricanes I immediately think “what about the dialysis patients?” #NephMadness
ICIs, SGLT2i, ARNI, ns-MRA,GLP-1RA—game changers in nephrology, but are we watching their electrolyte impact closely?
This table breaks it down!
👀 Surprised
📖 doi.org/10.1007/s101...
#Nephrology #OncoNephrology #MedSky #Electrolytes
ICIs, SGLT2i, ARNI, ns-MRA,GLP-1RA—game changers in nephrology, but are we watching their electrolyte impact closely?
This table breaks it down!
👀 Surprised
📖 doi.org/10.1007/s101...
#Nephrology #OncoNephrology #MedSky #Electrolytes
Abstract from SFM conference reported here www.medpagetoday.com/meetingcover...
ASAPP trial, N = 400 clinicaltrials.gov/study/NCT040...
Abstract from SFM conference reported here www.medpagetoday.com/meetingcover...
ASAPP trial, N = 400 clinicaltrials.gov/study/NCT040...
➡️10-15% of so called ADPKD do not have family history yet have PKD1/2 mutation.
➡️ Other genes involved in PKD (IFT40, CFAP47).
➡️10% of dialysis patients with unknown cause actually have genetic cause.
#ISNWCN
➡️10-15% of so called ADPKD do not have family history yet have PKD1/2 mutation.
➡️ Other genes involved in PKD (IFT40, CFAP47).
➡️10% of dialysis patients with unknown cause actually have genetic cause.
#ISNWCN